ADNCD
   
 
 
Select Mode of Action
Anti-diabetic mode of action: Hypoglycemic /Anti-diabetic activity
Natural compounds showing Hypoglycemic activity/Anti-diabetic activity
S.No. Compound Reference Activity shown Physicochemical Properties and Toxicity Risks
1 IsoliquiritigeninGaur et al., 2014Anti-diabetic activity Properties and Risk Assessment
2 LiquiritigeninGaur et al., 2014Anti-diabetic activity Properties and Risk Assessment
3 TolbutamideDeRuiter, 2003Hypoglycemic activity Properties and Risk Assessment
4 Hypoglycin BChen et al., 1957Hypoglycemic activity Properties and Risk Assessment
5 Lithosperman BKonno et al., 1985Hypoglycemic activity Properties and Risk Assessment
6 MyrtillinGraph et al., 2010Hypoglycemic activity Properties and Risk Assessment
7 LeucopelargonidinCherian and Augusti, 1993Hypoglycemic activity Properties and Risk Assessment
8 Betavulgarosides 2Murakami et al.,1999Hypoglycemic activity Properties and Risk Assessment
9 Indoleacetic AcidMirsky and Diengott, 1956Hypoglycemic activity Properties and Risk Assessment
10 LepidineShukla et al., 2012Hypoglycemic activity Properties and Risk Assessment
11 Methylenecyclopropyl GlycineMelde et al., 1989Hypoglycemic activity Properties and Risk Assessment
12 NigelloneEl-Dakhakhny et al.,2002Hypoglycemic activity Properties and Risk Assessment
13 IsoorientinSezik et al., 2005Hypoglycemic activity Properties and Risk Assessment
14 Kaurenoic Acid[Bresciania et al., 2004Hypoglycemic activity Properties and Risk Assessment
15 DioscoretineIwu et al., 1990Hypoglycemic activity Properties and Risk Assessment
16 LeurosineIslam et al., 2009 Hypoglycemic activity Properties and Risk Assessment
17 LochnerineIslam et al., 2009 Hypoglycemic activity Properties and Risk Assessment
18 TetrahydroalstonineIslam et al., 2009 Kocialski et al., 1972 Hypoglycemic activity Properties and Risk Assessment
19 VindolineIslam et al., 2009 Hypoglycemic activity Properties and Risk Assessment
20 VindolinineIslam et al., 2009 Hypoglycemic activity Properties and Risk Assessment
21 TecomineHammouda and Amer, 1996Hypoglycemic activity Properties and Risk Assessment
22 TecostanineHammouda and Amer, 1996Hypoglycemic activity Properties and Risk Assessment
23 Ganoderan A Hikino et al., 1985Hypoglycemic activity Properties and Risk Assessment
24 Trans-Dehydrocrotonin Silva et al., 2001 Farias et al., 1997Hypoglycemic activity Properties and Risk Assessment
25 GymnemageninThakur et al., 2012 Dholi et al., 2014Hypoglycemic activity Properties and Risk Assessment
26 Shikimic acidOrhan et al., 2012Hypoglycemic activity Properties and Risk Assessment
27 VincamineBenzi et al., 1984Hypoglycemic activity Properties and Risk Assessment
28 (-)-eburnamonineBenzi et al., 1984Hypoglycemic activity Properties and Risk Assessment
29 L-EphedrineXiu et al., 2001 Hypoglycemic activity Properties and Risk Assessment
30 Gymnemic acids IV Sugihara et al., 2000Hypoglycemic activity Properties and Risk Assessment
31 DaurisolinePerera and Li, 2012Hypoglycemic activity Properties and Risk Assessment
32 CryptolepineBierer et al., 1998Hypoglycemic activity Properties and Risk Assessment
33 CycloartenonePerera and Li, 2012Hypoglycemic activity Properties and Risk Assessment
34 AchyrofuranCarney et al., 2002Hypoglycemic activity Properties and Risk Assessment
35 LiensininePerera and Li, 2012Hypoglycemic activity Properties and Risk Assessment
36 FagomineNojima et al., 1998Hypoglycemic activity Properties and Risk Assessment
37 LophenolTanaka et al., 2006 Misawa et al., 2008 Hypoglycemic activity Properties and Risk Assessment
38 24-methyl-lophenolTanaka et al., 2006Hypoglycemic activity Properties and Risk Assessment
39 24-ethyl-lophenolTanaka et al., 2006Hypoglycemic activity Properties and Risk Assessment
40 CycloartanolTanaka et al., 2006Hypoglycemic activity Properties and Risk Assessment
41 24-methylene-cycloartanolTanaka et al., 2006Hypoglycemic activity Properties and Risk Assessment
42 18beta-Glycyrrhetinic Acid Kalaiarasi and Pugalend, 2009Hypoglycemic activity Properties and Risk Assessment
43 InositolLakshmi et al., 2006Hypoglycemic activity Properties and Risk Assessment
44 Ganoderic acidPerera and Li, 2012Hypoglycemic activity Properties and Risk Assessment
45 DioscinPerera and Li, 2012Hypoglycemic activity Properties and Risk Assessment
46 CoumarinVerma et al., 2013Hypoglycemic activity Properties and Risk Assessment
47 GalactomannanKamble et al., 2014Hypoglycemic activity Properties and Risk Assessment